Commentary on COVID-19 vaccine hesitancy in sub-Saharan Africa

dc.contributor.authorKabakama, Severin
dc.contributor.authorKonje, Eveline T.
dc.contributor.authorDinga, Jerome Nyhalah
dc.contributor.authorKishamawe, Colman
dc.contributor.authorMorhason-Bello, Imran
dc.contributor.authorHayombe, Peter
dc.contributor.authorAdeyemi, Olufela
dc.contributor.authorChimuka, Ernest
dc.contributor.authorLumu, Ivan
dc.contributor.authorAmuasi, John
dc.contributor.authorAcheampong, Theophilus
dc.contributor.authorDzinamarira, Tafadzwa
dc.date.accessioned2023-10-24T08:58:49Z
dc.date.available2023-10-24T08:58:49Z
dc.date.issued2022-07-11
dc.description.abstractRates of vaccination against COVID-19 remain lower in sub-Saharan Africa than in other low and middle-income regions. This is, in part, attributed to vaccine hesitancy, mainly due to misinformation about vaccine origin, efficacy and safety. From August to December 2021, we gathered the latest experiences and opinions on four vaccine hesitancy-related areas (policies, perceived risk religious beliefs, and misinformation) from 12 sub-Saharan African researchers, four of whom have published about COVID-19 vaccine hesitancy. The authors included two political and business experts, six public health specialists, five epidemiologists, and four biostatisticians from ten sub- Saharan African countries( Cameroon, Ghana, Kenya, Liberia, Nigeria, Sierra Leone, South Africa, Tanzania, Uganda, and Zimbabwe). The authors’ overarching opinions were that political influences, religious beliefs and low perceived risk exists in sub-Saharan Africa, and they collectively contribute to COVID-19 vaccine hesitancy. Communication strategies should target populations initially thought by policy makers to be at low risk, use multiple communication avenues and address major concerns in the population.en_US
dc.description.departmentSchool of Health Systems and Public Health (SHSPH)en_US
dc.description.librarianam2023en_US
dc.description.sponsorshipThe Bill and Melinda Gates Foundation.en_US
dc.description.urihttps://www.mdpi.com/journal/tropicalmeden_US
dc.identifier.citationKabakama, S.; Konje, E.T.; Dinga, J.N.; Kishamawe, C.; Morhason-Bello, I.; Hayombe, P.; Adeyemi, O.; Chimuka, E.; Lumu, I.; Amuasi, J.; et al. Commentary on COVID-19 Vaccine Hesitancy in sub-Saharan Africa. TTropical Medicine and Infectious Disease 2022, 7, 130. https://DOI.org/10.3390/tropicalmed7070130.en_US
dc.identifier.issn2414-6366
dc.identifier.other10.3390/tropicalmed7070130
dc.identifier.urihttp://hdl.handle.net/2263/93022
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_US
dc.subjectVaccine hesitancyen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectSub-Saharan Africa (SSA)en_US
dc.titleCommentary on COVID-19 vaccine hesitancy in sub-Saharan Africaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kabakama_Commentary_2022.pdf
Size:
203.52 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: